FindMyKOL
Clinical trialNCT00445978CompletedPhase 2Interventional

A Phase 2 Study of the Effects of 6R-BH4 in Subjects With Sickle Cell Disease

SponsorBioMarin PharmaceuticalEnrollment32Sickle Cell Disease
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This Phase 2a, multicenter, open-label, dose-escalation study is designed to assess the safety and biologic activity of daily oral administration of 4 escalating doses of sapropterin dihydrochloride over 16 weeks in subjects with sickle cell disease. During an optional extension phase, the study will assess the safety, tolerability, and efficacy of extended treatment with sapropterin dihydrochloride, for a total of up to 2 years; The extension phase of this study was terminated.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Facility name not stated

    Washington D.C., District of Columbia, United States

  • Facility name not stated

    Augusta, Georgia, United States

  • Facility name not stated

    Savannah, Georgia, United States

  • Facility name not stated

    Indianapolis, Indiana, United States

  • Facility name not stated

    Detroit, Michigan, United States

  • Facility name not stated

    Flint, Michigan, United States

  • Facility name not stated

    Hackensack, New Jersey, United States

  • Facility name not stated

    Chapel Hill, North Carolina, United States

  • Facility name not stated

    Philadelphia, Pennsylvania, United States

  • Facility name not stated

    Galveston, Texas, United States

  • Facility name not stated

    Norfolk, Virginia, United States

  • Facility name not stated

    Richmond, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2007
Primary completion
31 Aug 2008
Completion
30 Jun 2009
Last update posted
25 Feb 2021
Registered enrollment
32
Registry id
NCT00445978

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.